Coagulase-negative staphylococcal bacteraemia treated with teicoplanin. - Suppr | 超能文献

Coagulase-negative staphylococcal bacteraemia treated with teicoplanin.

作者信息

O'Connell B, Browne P V, Cafferkey M T, McCann S R

出版信息

J Antimicrob Chemother. 1993 Mar;31(3):438-9. doi: 10.1093/jac/31.3.438.

DOI:10.1093/jac/31.3.438

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Coagulase-negative staphylococcal bacteraemia treated with teicoplanin.

J Antimicrob Chemother. 1993 Mar;31(3):438-9. doi: 10.1093/jac/31.3.438.

2

Teicoplanin-resistant coagulase-negative staphylococcal bacteraemia in patients with haematological malignancies: a problem of increasing importance.血液系统恶性肿瘤患者中耐替考拉宁凝固酶阴性葡萄球菌菌血症：一个日益重要的问题。

J Antimicrob Chemother. 1997 Nov;40(5):738-40. doi: 10.1093/jac/40.5.738.

3

Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology.从血液感染中分离出的凝固酶阴性葡萄球菌的特征：发病率、对糖肽类的敏感性及分子流行病学

Eur J Clin Microbiol Infect Dis. 2002 Sep;21(9):660-5. doi: 10.1007/s10096-002-0799-9. Epub 2002 Sep 7.

4

Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis.替考拉宁与万古霉素封管疗法治疗导管相关凝固酶阴性葡萄球菌菌血症的有效性：一项前瞻性病例系列分析。

Int J Antimicrob Agents. 2009 Nov;34(5):482-5. doi: 10.1016/j.ijantimicag.2009.06.020. Epub 2009 Aug 26.

5

Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase-negative staphylococci.凝固酶阴性葡萄球菌分离株中糖肽类药物使用与替考拉宁敏感性降低之间的关系。

Eur J Clin Microbiol Infect Dis. 2004 May;23(5):375-9. doi: 10.1007/s10096-004-1129-1. Epub 2004 Apr 27.

6

Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci.凝固酶阴性葡萄球菌对糖肽类抗生素万古霉素和替考拉宁的耐受性

Antimicrob Agents Chemother. 2007 Feb;51(2):740-3. doi: 10.1128/AAC.00719-06. Epub 2006 Nov 20.

7

Clinical Characteristics of Methicillin-resistant Coagulase-negative Staphylococcal Bacteremia in a Tertiary Hospital.三级医院耐甲氧西林凝固酶阴性葡萄球菌菌血症的临床特征

Intern Med. 2017;56(7):781-785. doi: 10.2169/internalmedicine.56.7715. Epub 2017 Apr 1.

8

Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study.引起菌血症的凝固酶阴性葡萄球菌中的糖肽类耐药性：一项病例对照研究的流行病学和临床发现

Clin Infect Dis. 2001 Nov 15;33(10):1628-35. doi: 10.1086/323676. Epub 2001 Oct 5.

9

[Bacteremia caused by coagulase-negative staphylococci: incidence, frequency of teicoplanin resistance and molecular epidemiology].[凝固酶阴性葡萄球菌引起的菌血症：发生率、替考拉宁耐药频率及分子流行病学]

Pathol Biol (Paris). 2002 Nov;50(9):552-9. doi: 10.1016/s0369-8114(02)00347-4.

10

Microbial characteristics and severity of coagulase-negative staphylococcal septicaemia in premature neonates.早产儿凝固酶阴性葡萄球菌败血症的微生物特征及严重程度

Early Hum Dev. 1995 Aug 18;42(3):235-9. doi: 10.1016/0378-3782(95)01652-j.

引用本文的文献

1

Current perspectives on glycopeptide resistance.糖肽类耐药性的当前观点

Clin Microbiol Rev. 1995 Oct;8(4):585-615. doi: 10.1128/CMR.8.4.585.

2

Anti-infective treatment in intensive care: the role of glycopeptides.重症监护中的抗感染治疗：糖肽类药物的作用

Intensive Care Med. 1994 Nov;20 Suppl 4:S17-22. doi: 10.1007/BF01713978.

3

Teicoplanin: 10 years of clinical experience.替考拉宁：10年临床经验

Infection. 1994 Nov-Dec;22(6):430-6. doi: 10.1007/BF01715507.